Keeping Track: Rebuff Of Iclaprim Creates Early Pileup Of CRLs For Novel Drugs

19 Feb 2019

• By Michael Cipriano and Bridget Silverman

The latest drug development news and highlights from our US FDA Performance Tracker.

More from Product Reviews